Michelle Berrey

Michelle Berrey is an accomplished medical professional and executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Board Member for Virion Therapeutics, OCEAN BIOMEDICAL, and the North Carolina Biotechnology Center, Michelle Berrey also operates as an Independent Consultant. Previously, Michelle held key leadership roles, including President R&D and Chief Medical Officer at Intercept Pharmaceuticals, and President & CEO at Chimerix, Inc. Education credentials include an MD from the Medical College of Georgia, an MPH from Emory University, and a BA in English from Emory University. Michelle Berrey's expertise encompasses R&D leadership and guidance in clinical pharmacology and infectious diseases.